Rheumatoid myopathy occurring as an extraarticular manifestation of seropositive rheumatoid arthritis, documented at multiple joint sites simultaneously.

Documentation tips

What should appear in the chart to support M05.49.

Source · Editorial brief grounded in 5 cited references ↓

• Explicitly document rheumatoid factor positivity (lab value or prior confirmed seropositivity) to justify the M05 category over M06.
• Record the specific joints involved — even when coding 'multiple sites,' the note should name them to support medical necessity and withstand audit.
• Document the myopathic findings: proximal muscle weakness, abnormal CK/aldolase, EMG changes, or muscle biopsy results that confirm myopathy rather than arthralgia alone.
• If disease-modifying therapy (DMARD, biologic) is being managed at the same encounter, note the agent and dosing — supports medical necessity for infusion or injection CPT codes.
• Distinguish inflammatory myopathy from steroid-induced myopathy (a treatment side effect); if both are present, code each separately with appropriate sequencing.

Related CPT procedures

Procedure codes commonly billed with M05.49. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M05.49 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

• Assigning M05.49 when rheumatoid factor status is undocumented or negative — seronegative RA with myopathy belongs under M06, not M05.
• Using M05.49 as a catch-all for diffuse RA joint pain without documented myopathy; the code requires both the arthritis AND muscle involvement to be clinically established.
• Choosing M05.49 when only one joint is involved — single-site myopathy with RA should use the site-specific M05.41–M05.479 codes.
• Failing to query the provider when the problem list says 'RA' (M05.9) but the note body describes muscle weakness — the specificity gap creates an HCC risk and downcodes the encounter.
• Coding M05.49 alongside a separate inflammatory myopathy code (e.g., M60.xx) without verifying whether both diagnoses are independently documented or whether the myopathy is entirely attributable to RA.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

Sibling codes

Other billable codes under M05.4 (laterality / anatomic variants).